FDA Inspection 967917 — University Of Maryland Medical Center RDRC
The FDA completed an inspection of University Of Maryland Medical Center RDRC on Apr 13, 2016 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 13, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baltimore, MD (United States)
Additional Details
Radioactive Drug Research Committee